All In MedTech

Device Trial Radar · NCT01181440

Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers

A Prospective, Multicenter, Randomized, Single-Blind Clinical Investigation of Dermagraft(R) in Patients With Plantar Diabetic Foot Ulcers

Last checked: Nov 20, 2026Latest source record: May 21, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 281 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

281

Actual

Start

Sep 1994

Primary completion

Jan 1997

Study completion Jan 1997

Sponsor

Lead sponsor
OrganogenesisNot on our public-company list
Sponsor type
Industry
First posted
Aug 13, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study randomly assigns patients with plantar diabetic foot ulcers to receive conventional therapy (debridement, infection control, saline-moistened gauze dressings, and standardized off-weighting) alone or conventional therapy plus Dermagraft(R). Dermagraft is a device containing live human fibroblasts grown on an absorbable polyglactin (Vicryl) mesh. Patients are evaluated weekly until Week 12, then every four weeks until Week 32.

Conditions

  • Diabetic Foot Ulcer

Interventions

  • Dermagraft(R)Device

    Weekly application of Dermagraft(R) with conventional care

  • Conventional careOther

    Weekly application of conventional care

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients with complete wound closureTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Richard Pollak, DPM

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.